Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients

Emerg Infect Dis. 2005 Jun;11(6):966-8. doi: 10.3201/eid1106.050142.

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections increased from 2000 to 2003 in hospitalized pediatric patients in Houston. CA-MRSA was associated with greater illness than was infection with methicillin-susceptible strains. Children with CA-MRSA were younger and mostly African American. Of MRSA isolates, 4.5% had the inducible macrolide-lincosamide-streptogramin B phenotype.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / epidemiology*
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / physiopathology*
  • Female
  • Hospitalization*
  • Humans
  • Infant
  • Male
  • Methicillin / pharmacology
  • Methicillin Resistance*
  • Microbial Sensitivity Tests
  • Pediatrics
  • Prevalence
  • Retrospective Studies
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / physiopathology
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / pathogenicity*

Substances

  • Anti-Bacterial Agents
  • Methicillin